Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 2401 AL 2415

A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease

Chhabra A, Solanki S, Saravanabawan P, Venkiteswaran A, Nimmathota N, Modi NM.

Expert Opin Biol Ther. 2024 Nov;24(11):1261-1269. doi: 10.1080/14712598.2024.2416947. Epub 2024 Nov 12.

Surface engineered nano architectonics: An evolving paradigm for tackling Alzheimer's disease

Negi M, Amulya E, Phatale V, Abraham N, Hedaoo A, Srinivasarao DA, Srivastava S.

Life Sci. 2024 Dec 1;358:123155. doi: 10.1016/j.lfs.2024.123155. Epub 2024 Oct 19.

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy

Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenmüller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk R; Alzheimer's Disease Metabolomics Consortium (ADMC).

Alzheimers Dement. 2024 Dec;20(12):8294-8307. doi: 10.1002/alz.14249. Epub 2024 Oct 22.

Gut microbiome-derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics

Chandra S, Vassar RJ.

Immunol Rev. 2024 Oct;327(1):33-42. doi: 10.1111/imr.13412. Epub 2024 Oct 23.

The potential role of transcription factor sterol regulatory element binding proteins (SREBPs) in Alzheimer's disease

Liu S, Li X, Fan P, Gu Y, Yang A, Wang W, Zhou L, Chen H, Zheng F, Lin J, Xu Z, Zhao Q.

Biomed Pharmacother. 2024 Nov;180:117575. doi: 10.1016/j.biopha.2024.117575. Epub 2024 Oct 22.

Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease

Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H, Tassi I, Ward M, Yeh F, Schwabe T, Paul R, Kenkare-Mitra S, Rosenthal A.

Alzheimers Res Ther. 2024 Oct 23;16(1):235. doi: 10.1186/s13195-024-01599-1.

Current insights into apolipoprotein E and the immune response in Alzheimer's disease

Lin PB, Holtzman DM.

Immunol Rev. 2024 Oct;327(1):43-52. doi: 10.1111/imr.13414. Epub 2024 Oct 24.

Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer's Disease

Tsoy A, Umbayev B, Kassenova A, Kaupbayeva B, Askarova S.

Int J Mol Sci. 2024 Oct 11;25(20):10964. doi: 10.3390/ijms252010964.

Novelties on Neuroinflammation in Alzheimer's Disease-Focus on Gut and Oral Microbiota Involvement

Popescu C, Munteanu C, Anghelescu A, Ciobanu V, Spînu A, Andone I, Mandu M, Bistriceanu R, Băilă M, Postoiu RL, Vlădulescu-Trandafir AI, Giuvara S, Malaelea AD, Onose G.

Int J Mol Sci. 2024 Oct 19;25(20):11272. doi: 10.3390/ijms252011272.

Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention

Gonçalves M, Costa M, Paiva-Martins F, Silva P.

Molecules. 2024 Oct 12;29(20):4841. doi: 10.3390/molecules29204841.

The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings

Yang J, Liang J, Hu N, He N, Liu B, Liu G, Qin Y.

CNS Neurosci Ther. 2024 Oct;30(10):e70091. doi: 10.1111/cns.70091.

Gut microbial metabolism in Alzheimer's disease and related dementias

Kang JW, Vemuganti V, Kuehn JF, Ulland TK, Rey FE, Bendlin BB.

Neurotherapeutics. 2024 Oct;21(6):e00470. doi: 10.1016/j.neurot.2024.e00470. Epub 2024 Oct 28.

Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment

Reiss AB, Housny M, Gulkarov S, Hossain T, Locke B, Srivastava A, Pinkhasov A, Gomolin IH, Wisniewski T, De Leon J.

Discov Med. 2024 Oct;36(189):1917-1932. doi: 10.24976/Discov.Med.202436189.179.

The Role of Non-Coding RNAs in Mitochondrial Dysfunction of Alzheimer's Disease

Abed S, Ebrahimi A, Fattahi F, Kouchakali G, Shekari-Khaniani M, Mansoori-Derakhshan S.

J Mol Neurosci. 2024 Oct 28;74(4):100. doi: 10.1007/s12031-024-02262-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias